The week at Retraction Watch featured the retraction of a paper from Yale on ketamine and depression, a retraction for Carlo Croce, and a discussion of when a citation may not be enough. Here’s what was happening elsewhere:
Does failing to disclose that you were once a leader in the “Axis of Evil” deserve retraction? An engineering journal has pulled a 2017 paper whose authors included Mahmoud Ahmadinejad, former president of the Islamic Republic of Iran. Ahmadinejad, the notorious anti-Semitic and anti-West president of Iran from 2005 to 2013, was a civil engineer … Continue reading Engineering journal removes article co-authored by former president of Iran
A psychiatry journal has retracted a 2011 paper exploring the use of ketamine to treat patients with severe depression following an investigation at Yale University. According to the retraction notice, Yale determined that the paper, published in the International Journal of Neuropsychopharmacology, did not accurately describe the research. But the study’s lead author, Gregory Larkin, … Continue reading Ketamine-depression paper retracted following investigation at Yale
Pfizer has discovered two additional papers that merit retraction from the lab of a former employee. One of the papers, published in Clinical Cancer Research, was retracted earlier this month. Last year, Pfizer requested retractions of five papers from the lab of breast cancer researcher Min-Jean Yin, who was fired after an investigation revealed image duplication. … Continue reading Case closed? Fired Pfizer researcher slated for seven retractions
The week at Retraction Watch featured the revocation of a PhD, a questionable way to boost university rankings, and a look at what editors should do when a researcher known to have committed misconduct submits a new manuscript. Here’s what was happening elsewhere:
A group of researchers have retracted their 2016 case report about a rare dermatologic disorder in the wake of disputes about authorship and institutional approval. The paper describes a young boy with Job’s Syndrome, in which patients experience painful, itchy and frequently disfiguring skin lesions, along with a constellation of other possible symptoms. The condition … Continue reading Hey, that’s my case study: Another retraction after doctors claim rights to case write-up
Readers who follow scientific publishing will know the term “citation stacking” — as a profile-boosting technique, we’ve seen journals ask authors to cite them, and individual scientists work together to cite each other, forming “citation cartels.” And now, we’ve seen a university do it. A university in Malaysia has instructed its engineering faculty to cite … Continue reading One way to boost your uni’s ranking: Ask faculty to cite each other
Earlier this year, a raging controversy regarding a new drug spilled into the pages of a leading medical journal: the head of the U.S. Food and Drug Administration and another official publicly called for the retraction or correction of a peer-reviewed article about the drug. They didn’t get their wish. Now, documents released by the … Continue reading Released FDA docs reveal details of agency’s (failed) attempt to retract paper
In June, Gene Emery, a journalist for Reuters Health, was assigned to write a story about an upcoming paper in the Journal of the American College of Cardiology, set to come off embargo and be released to the public in a few days. Pretty quickly, he noticed something seemed off. Emery saw that the data … Continue reading Journal knew about problems in a high-profile study before it came out — and did nothing for over a month
In 2014, researchers condemned the Spanish Government for “destroying the R&D horizon of Spain and the future of a complete generation” in the acknowledgment section of a paper about wireless networks. Three years later, the two last authors of the paper are protesting that protest, issuing a correction to alert readers that they did not … Continue reading Curious: A paper’s acknowledgments harshly criticized Spanish gov’t funding. Now two authors object.